{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:02:34Z","timestamp":1778508154752,"version":"3.51.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Although obesity has become a significant problem in transplantation medicine, the impact of different immunosuppressive protocols on clinical outcomes in obese transplant recipients remains unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed an analysis of the Scientific Registry of Transplant Recipients database. Kidney transplant recipients were categorized according to body mass index (BMI) categories and immunosuppressive protocols: (i) tacrolimus\/mycophenolate mofetil (Tac-MMF), (ii) mTOR-inhibitor\/Tac (mTORi-Tac), (iii) mTORi\/cyclosporin (mTORi-Cyc) and (iv) mTORi-MMF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Graft recipients with advanced obesity (BMI \u226535\u00a0kg\/m2) exhibited significantly lower rates of acute rejection during the first year after transplantation in the mTORi-Tac (6.4%) group compared with Tac-MMF (11.2%). Obesity class 1 (30\u00a0&amp;lt;\u00a0BMI\u00a0&amp;lt;\u00a035\u00a0kg\/m2) was associated with a significant risk of acute rejection for the mTORi-Tac group [obesity class 1 hazard ratio (HR) 1.79, 95% confidence interval (CI) 1.21\u20132.62, P\u00a0=\u00a0.003]. A similar trend was observed in the Tac-MMF group for advanced obesity HR 1.29; 95% CI 0.96\u20131.73, P\u00a0=\u00a0.087). For the Tac-MMF group, recipients with both overweight and obesity had significantly impaired survival due to cardiovascular events and also increased mortality due to infection in advanced obesity. Combination of mTORi and calcineurin inhibitor was associated with lower rejection rates and stable long-term kidney function while reducing cardiovascular side effects linked to calcineurin inhibitors in obese kidney graft recipients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These results are critical for the growing number of obese graft recipients and warrant prospective evaluation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ndt\/gfad014","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T15:30:41Z","timestamp":1674228641000},"page":"2052-2066","source":"Crossref","is-referenced-by-count":1,"title":["Impact of different immunosuppressive protocols on clinical outcomes in obese kidney transplant recipients: a propensity score\u2013matched analysis"],"prefix":"10.1093","volume":"38","author":[{"given":"Lina Maria","family":"Serna-Higuita","sequence":"first","affiliation":[{"name":"Institute for Clinical Epidemiology and Applied Biostatistics, Medical University of T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9838-3083","authenticated-orcid":false,"given":"Andrea","family":"Della Penna","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplant Surgery, University Hospital T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4294-980X","authenticated-orcid":false,"given":"Martina","family":"Guthoff","sequence":"additional","affiliation":[{"name":"Department of Diabetology, Endocrinology, Nephrology, Section of Nephrology and Hypertension, University Hospital T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Heyne","sequence":"additional","affiliation":[{"name":"Department of Diabetology, Endocrinology, Nephrology, Section of Nephrology and Hypertension, University Hospital T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Beer-Hammer","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Experimental Therapy & Toxicology and Interfaculty Center of Pharmacogenomics & Drug Research (IZePhA), University Hospitals and Clinics, Eberhard Karls University T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Nadalin","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplant Surgery, University Hospital T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Martus","sequence":"additional","affiliation":[{"name":"Institute for Clinical Epidemiology and Applied Biostatistics, Medical University of T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2301-4080","authenticated-orcid":false,"given":"Alfred","family":"K\u00f6nigsrainer","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplant Surgery, University Hospital T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Quante","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplant Surgery, University Hospital T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"2023083104265313200_bib1","author":"Obesity and overweight [Internet]","year":"2021"},{"key":"2023083104265313200_bib2","first-page":"1403","article-title":"Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis","volume-title":"Nephrol Dial Transplant","author":"Hill","year":"2015"},{"key":"2023083104265313200_bib3","first-page":"128","article-title":"Obesity in patients undergoing dialysis and kidney transplantation","volume-title":"Adv Chronic Kidney Dis","author":"Friedman","year":"2013"},{"key":"2023083104265313200_bib4","first-page":"439","article-title":"Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis","volume-title":"Nephrol Dial Transplant","author":"Ladhani","year":"2017"},{"key":"2023083104265313200_bib5","first-page":"480","article-title":"Demographics and trends in overweight and obesity in patients at time of kidney transplantation","volume-title":"Am J Kidney Dis","author":"Friedman","year":"2003"},{"key":"2023083104265313200_bib6","first-page":"10","article-title":"Obesity and its impact on transplantation and alloimmunity","volume-title":"Transplantation","author":"Heinbokel","year":"2013"},{"key":"2023083104265313200_bib7","first-page":"1093","article-title":"Effect of obesity on clinical outcomes of kidney transplant patients","volume-title":"Transplant Proc","author":"Erturk","year":"2019"},{"key":"2023083104265313200_bib8","first-page":"717","article-title":"Does pretransplant obesity affect the outcome in kidney transplant recipients?","volume-title":"Transplant Proc","author":"Singh","year":"2005"},{"key":"2023083104265313200_bib9","first-page":"218","article-title":"Higher recipient body mass index is associated with post-transplant delayed kidney graft function","volume-title":"Kidney Int","author":"Molnar","year":"2011"},{"key":"2023083104265313200_bib10","first-page":"229","article-title":"Tacrolimus exposure in obese patients: and a case-control study in kidney transplantation","volume-title":"Ther Drug Monit","author":"Robert","year":"2021"},{"key":"2023083104265313200_bib11","first-page":"1","article-title":"Rapamycin delays allograft rejection in obese graft recipients through induction of myeloid-derived suppressor cells","volume-title":"Immunol Lett","author":"Deissler","year":"2021"},{"key":"2023083104265313200_bib12","first-page":"186","article-title":"Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation","volume-title":"Kidney Int","author":"Raynaud","year":"2021"},{"key":"2023083104265313200_bib13","first-page":"1737","article-title":"New creatinine- and cystatin c-based equations to estimate GFR without race","volume-title":"N Engl J Med","author":"Inker","year":"2021"},{"key":"2023083104265313200_bib14","first-page":"2562","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume-title":"N Engl J Med","author":"Ekberg","year":"2007"},{"key":"2023083104265313200_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/atm.2018.12.10","article-title":"Balance diagnostics after propensity score matching","volume":"7","author":"Zhang","year":"2019","journal-title":"Ann Transl Med"},{"key":"2023083104265313200_bib16","first-page":"601","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume-title":"Circulation","author":"Austin","year":"2016"},{"key":"2023083104265313200_bib17","first-page":"47","article-title":"Survival analysis in the presence of competing risks","volume-title":"Ann Transl Med","author":"Zhang","year":"2017"},{"key":"2023083104265313200_bib18","first-page":"585","article-title":"Multiple imputation in health-care databases: an overview and some applications","volume-title":"Stat Med","author":"Rubin","year":"1991"},{"key":"2023083104265313200_bib19","first-page":"4","article-title":"Multiple imputation as a flexible tool for missing data handling in clinical research","volume-title":"Behav Res Ther","author":"Enders","year":"2017"},{"key":"2023083104265313200_bib20","first-page":"37","article-title":"Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: prevention and treatment","volume-title":"Transplant Rev (Orlando)","author":"Wissing","year":"2014"},{"key":"2023083104265313200_bib21","first-page":"1015","article-title":"High-fat diet-induced obesity enhances allograft rejection","volume-title":"Transplantation","author":"Molinero","year":"2016"},{"key":"2023083104265313200_bib22","first-page":"402","article-title":"Taurodeoxycholic acid and valine reverse obesity-associated augmented alloimmune responses and prolong allograft survival","volume-title":"Am J Transplant","author":"Quante","year":"2022"},{"key":"2023083104265313200_bib23","first-page":"324","article-title":"Validating early post-transplant outcomes reported for recipients of deceased donor kidney transplants","volume-title":"Clin J Am Soc Nephrol","author":"Potluri","year":"2016"},{"key":"2023083104265313200_bib24","first-page":"535","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume-title":"Am J Transplant","author":"Vincenti","year":"2010"},{"key":"2023083104265313200_bib25","first-page":"1633","article-title":"The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients","volume-title":"Am J Transplant","author":"Flechner","year":"2011"},{"key":"2023083104265313200_bib26","first-page":"231","article-title":"An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients","volume-title":"Kidney Int","author":"Sommerer","year":"2019"},{"key":"2023083104265313200_bib27","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.transproceed.2005.02.055","article-title":"High initial blood levels of tacrolimus in overweight renal transplant recipients","volume-title":"Transplant Proc","author":"Rodrigo","year":"2005"},{"key":"2023083104265313200_bib28","first-page":"e129","article-title":"Overweight kidney transplant recipients are at risk of being overdosed following standard bodyweight-based tacrolimus starting dose","volume-title":"Transplant Direct","author":"Andrews","year":"2017"},{"key":"2023083104265313200_bib29","first-page":"e59","article-title":"Development of a physiologically-based pharmacokinetic model for sirolimus: predicting bioavailability based on intestinal CYP3A content","volume-title":"CPT Pharmacometrics Syst Pharmacol","author":"Emoto","year":"2013"},{"key":"2023083104265313200_bib30","first-page":"57","article-title":"Surgical biology for the clinician: vascular effects of immunosuppression","volume-title":"Can J Surg","author":"Tepperman","year":"2010"},{"key":"2023083104265313200_bib31","first-page":"e984","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association.","volume-title":"Circulation","author":"Powell-Wiley","year":"2021"},{"key":"2023083104265313200_bib32","first-page":"39","article-title":"Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study","volume-title":"Am J Kidney Dis","author":"Foster","year":"2008"},{"key":"2023083104265313200_bib33","first-page":"871","article-title":"Association between body mass index and CKD in apparently healthy men","volume-title":"Am J Kidney Dis","author":"Gelber","year":"2005"},{"key":"2023083104265313200_bib34","first-page":"1003","article-title":"Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size","volume-title":"Clin J Am Soc Nephrol","author":"Michels","year":"2010"},{"key":"2023083104265313200_bib35","first-page":"1129","article-title":"The estimation of GFR and the adjustment for BSA in overweight and obesity: a dreadful combination of two errors","volume-title":"Int J Obes (Lond)","author":"Lopez-Martinez","year":"2020"},{"key":"2023083104265313200_bib36","first-page":"699","article-title":"Cyclosporine-associated chronic nephropathy","volume-title":"N Engl J Med","author":"Myers","year":"1984"},{"key":"2023083104265313200_bib37","first-page":"1264","article-title":"Long-term immunosuppression management: opportunities and uncertainties","volume-title":"Clin J Am Soc Nephrol","author":"Wojciechowski","year":"2021"},{"key":"2023083104265313200_bib38","volume-title":"The Role of Public Health Organizations in Addressing Public Health Problems in Europe: The Case of Obesity, Alcohol and Antimicrobial Resistance [Internet]","author":"Rechel","year":"2018"},{"key":"2023083104265313200_bib39","first-page":"3408","article-title":"Effect of degree of obesity on renal transplant outcome","volume-title":"Transplant Proc","author":"Cacciola","year":"2008"},{"key":"2023083104265313200_bib40","first-page":"1377","article-title":"Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis","volume-title":"Transplantation","author":"Meier-Kriesche","year":"2002"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfad014\/49880979\/gfad014.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/38\/9\/2052\/51277746\/gfad014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/38\/9\/2052\/51277746\/gfad014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T04:54:05Z","timestamp":1693457645000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/38\/9\/2052\/6994384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,1,20]]},"published-print":{"date-parts":[[2023,8,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfad014","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,1,20]]}}}